SCHEMBL5124458

SCHEMBL5124458

COC(=O)CN(c1c(Cl)sc(-c2ccccc2)c1Cl)S(N)(=O)=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM6 O15303 2/20 0.39
ALDH1A1 P00352 5/20 0.38
NR1I2 O75469 1/20 0.38
RAB9A P51151 1/20 0.37
PTPN1 P18031 2/20 0.36
PTPN6 P29350 1/20 0.36
PTPN11 Q06124 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GRM5 P41594 1/20 0.35
MAPT P10636 1/20 0.35
ACLY P53396 1/20 0.35
HIF1A Q16665 1/20 0.34
PKM P14618 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5112961 0.80 NR1I2 (0.42) ALDH1A1NR1I2RAB9APTPN1PTPN6
SCHEMBL5117056 0.74 ALDH1A1 (0.41) ALDH1A1NR1I2RAB9APTPN1PTPN6
SCHEMBL5128143 0.70 NR1I2 (0.44) ALDH1A1NR1I2RAB9APTPN1PTPN6
SCHEMBL2892656 0.65 ALDH1A1 (0.51) ALDH1A1RAB9APTPN1PTPN6PTPN11
SCHEMBL5283944 0.63 ALDH1A1 (0.71) ALDH1A1NR1I2RAB9APTPN1PTPN6
SCHEMBL3916479 0.63 PTPN1 (0.54) PTPN1ACLY
SCHEMBL2892950 0.62 ALDH1A1 (0.48) ALDH1A1PTPN1PTPN6PTPN11MAPK1
SCHEMBL10956866 0.62 NR1I2 (0.64) ALDH1A1NR1I2PTPN1MAPK1SMN1; SMN2
SCHEMBL5286157 0.61 NR1I2 (0.76) ALDH1A1NR1I2RAB9APTPN1MAPK1
SCHEMBL28147719 0.61 BMP1 (0.50) ALDH1A1NR1I2MAPK1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004325-A1 PTP1B inhibitors WYETH (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004325-A1 PTP1B inhibitors PTPA, PTPRJ, PTPRR GRM6 2198/4885ALDH1A1 1266/4885NR1I2 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.